Related Experiment Video
Updated: Sep 10, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Preterm birth trends in the United States post aspirin recommendation guidelines
Mariam K Ayyash1, Huda B Al-Kouatly2, Majid Shaman3
1Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Columbia University Irving Medical Center, NY, NY, USA.
Objectives:
To evaluate changes in preterm birth (PTB) rates in the U.S. following the United States Preventive Services Task Force (USPSTF) aspirin recommendation guidelines.
Methods:
A retrospective cohort study was conducted using the US Natality database. The pre-aspirin (pre-ASA) group included births from 2010-2014, while the post-aspirin (post-ASA) group included births from 2016-2021. Births from 2015, the guideline publication year, were excluded. Outcomes were overall PTB rates (<37 weeks) and early PTB rates (<34 weeks). Univariable and multivariable analyses were performed. Projected trends based on 2010-2014 data were compared to observed trends post-guideline implementation to assess differences.
Results:
The pre-ASA group included 12.1 million births, and the post-ASA group included 17.6 million. Adjusted analyses showed lower PTB rates in the post-ASA group: <37 weeks (8.4 % vs 8.8 %; aOR 0.940 [0.937-0.944]) and <34 weeks (2.3 % vs 2.4 %; aOR 0.92 [0.910-0.923]). However, observed post-ASA trends closely followed projected trends until 2021, when PTB rates exceeded projections.
Conclusion:
Although adjusted analyses suggest modest reductions in PTB following USPSTF aspirin guidelines, observed trends did not show a clear reduction following aspirin implementation.
Related Concept Videos
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Venous Thrombosis III: Interprofessional Care
Teratogenicity
Regression Toward the Mean
Factors Affecting Drug Response: Overview
Pre-Procedural Guidelines for Assessing Blood Pressure

